Sequential therapy with mini-BEAM ESHAP for refractory non Hodgkin's lymphomas

被引：0
|
作者：
Caballero, MD [1 ]
Amigo, ML [1 ]
Hernandez, JM [1 ]
Vazquez, L [1 ]
delCanizo, C [1 ]
Gonzalez, M [1 ]
Garcia, R [1 ]
SanMiguel, JF [1 ]
机构：
[1] UNIV HOSP SALAMANCA,DEPT HAEMATOL,SALAMANCA,SPAIN
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1380 / 1380
页数：1
相关论文
共 50 条
  • [21] FEAM conditioning in Non Hodgkin/Hodgkin relapsed or refractory Lymphomas
    Bozzoli, V.
    Mazziotta, F.
    Orciuolo, E.
    Iovino, L.
    Buda, G.
    Ghio, F.
    Petrini, M.
    Messa, Anna Rita
    Forese, Pasquale
    Dargenio, Michela
    Matera, Rossella
    di Renzo, Nicola
    BONE MARROW TRANSPLANTATION, 2015, 50 : S444 - S444
  • [22] MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    COLWILL, R
    CRUMP, M
    COUTURE, F
    DANISH, R
    STEWART, AK
    SUTTON, DMC
    SCOTT, JG
    SUTCLIFFE, SB
    BRANDWEIN, JM
    KEATING, A
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) : 396 - 402
  • [23] Mini-BEAM for relapsed or refractory lymphoma prior to autologous bone marrow transplantation (ABMT)
    Girouard, C
    Dufresne, J
    Imrie, K
    Prince, M
    Stewart, AK
    Keating, A
    Crump, M
    BLOOD, 1995, 86 (10) : 203 - 203
  • [24] Surgical therapy of gastrointestinal non-Hodgkin's lymphomas
    Ernst, M
    Stein, H
    Ludwig, D
    BoeseLandgraf, J
    Riz, J
    Haring, R
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (02): : 177 - 181
  • [25] Hodgkin's and Non-Hodgkin's lymphomas
    Rademaker, Juergen
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2007, 45 (01) : 69 - +
  • [26] Reduced-intensity conditioning regimen with BEAM/rituximab for patients with refractory non-Hodgkin's lymphomas.
    Khouri, IF
    Saliba, RM
    Okoroji, GJ
    Acholonu, S
    Maadani, F
    Hosing, C
    Champlin, RE
    BLOOD, 2004, 104 (11) : 637A - 637A
  • [27] GDP (gemcitabine, dexamethasone, cisplatin) salvage therapy results in superior progression free survival compared to mini-beam prior to autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    BLOOD, 2004, 104 (11) : 258A - 259A
  • [28] ESHAP plus rituximab (ESHAP-R) regimen for relapsing or refractory non-Hodgkin's lymphoma (NHL): Study of four cases.
    Komaba, S
    Tashiro, H
    Noguchi, M
    Sanaka, T
    Gotoh, MA
    Kawasugi, K
    Shirafuji, N
    BLOOD, 2002, 100 (11) : 302B - 302B
  • [29] Current approaches to therapy for indolent non-Hodgkin's lymphomas
    Cheson, BC
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1357 - 1362
  • [30] Monoclonal antibody therapy of patients with non-Hodgkin's lymphomas
    Tesch, H
    Engert, A
    Manzke, O
    Diehl, V
    Schnell, R
    Bohlen, H
    ONKOLOGIE, 1999, 22 (01): : 18 - 24
12345